Overview
observational epidemiological study of patients affected by systemic amyloidosis
Eligibility
Inclusion Criteria:
- patients diagnosed with amyloidosis or asymptomatic carriers of mutations in the transthyretin gene
- minimum age of 18 years at the time of diagnosis
- obtaining informed consent
Exclusion Criteria:
- nothing